Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low-Dose Dexamethasone in the Treatment of Multiple Myeloma: A Matching Adjusted Indirect Comparison.
Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low-Dose Dexamethasone in the Treatment of Multiple Myeloma: A Matching Adjusted Indirect Comparison.
S. Van Sanden,Tetsuro Ito,3 Authors,A. Oriol
2018 · DOI: 10.1634/theoncologist.2017-0103
The Oncologist · 14 Citations
TLDR
It is suggested that daratumumab improves OS compared with pomalidomide + LoDex in patients with heavily pretreated multiple myeloma, and this matching adjusted indirect comparison provides useful insights to clinicians and reimbursement authorities around the relative efficacy of treatments.